Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxygen carriers ("blood substitutes").

L A Topfer, D Hailey

    Issues in Emerging Health Technologies
    |January 5, 2002
    PubMed
    Summary

    Oxygen carriers, or blood substitutes, are in clinical trials for surgical use to reduce allogeneic blood transfusions. Further research is needed to determine their benefits, safety, cost-effectiveness, and ideal patient populations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Caregivers' time utilization before and after the introduction of an electronic nursing documentation system in a residential aged care facility.

    Methods of information in medicine·2013
    Same author

    Open magnetic resonance imaging (MRI) scanners.

    Issues in emerging health technologies·2006
    Same author

    Digital mammography: an update.

    Issues in emerging health technologies·2006
    Same author

    Radiofrequency ablation in the treatment of kidney cancer.

    Issues in emerging health technologies·2006
    Same author

    Health technology assessment.

    Singapore medical journal·2006
    Same author

    Technology and managed care: is telemedicine the right tool for rural communities?

    Journal of postgraduate medicine·2006

    Area of Science:

    • Biomedical engineering
    • Hematology
    • Surgical innovation

    Background:

    • Oxygen carriers, also known as blood substitutes, are emerging medical products.
    • Several oxygen carriers are currently in clinical trials globally.
    • Some products, like Hemopure(R) and Hemolink(tm), are nearing market approval in specific regions.

    Purpose of the Study:

    • To evaluate the efficacy of oxygen carriers in minimizing allogeneic blood transfusions during surgery.
    • To compare the benefits of oxygen carriers against existing blood conservation strategies and allogeneic blood transfusions.
    • To assess the safety, cost-effectiveness, and optimal patient selection for oxygen carrier utilization.

    Main Methods:

    • Clinical trials investigating the use of oxygen carriers.
    • Comparative analysis of blood conservation technologies.
    • Safety and economic evaluations.

    Main Results:

    • Oxygen carriers are being tested primarily for surgical applications.
    • Regulatory approvals are pending or recently granted in some countries.
    • Ongoing trials aim to establish clinical utility and patient benefits.

    Conclusions:

    • Oxygen carriers show promise as alternatives to allogeneic blood transfusions.
    • Comprehensive studies are required to validate their comparative advantages and safety profiles.
    • Further investigation is essential to identify specific patient groups who would most benefit from these novel therapies.

    Related Experiment Videos